Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Ferrovial SE
AEX:FER
|
NL |
|
Loblaw Companies Ltd
TSX:L
|
CA |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
Iss A/S
CSE:ISS
|
DK |
Wall St Price Targets
REGN Price Targets Summary
Regeneron Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for REGN is 884.954 USD with a low forecast of 666.6 USD and a high forecast of 1 109.85 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is REGN's stock price target?
Price Target
884.954
USD
According to Wall Street analysts, the average 1-year price target for REGN is 884.954 USD with a low forecast of 666.6 USD and a high forecast of 1 109.85 USD.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 28%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
12%
The compound annual growth rate for Operating Income over the next 8 years is 12%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
The compound annual growth rate for Net Income over the next 8 years is 8%.
